A report on older-age bipolar disorder from the International Society for Bipolar Disorders Task Force

Bipolar Disorders

Volumn 17, Issue 7, 2015, Pages 689-704

  Sajatovic, Martha ^a   Strejilevich, Sergio A ^b   Gildengers, Ariel G ^c   Dols, Annemiek ^d   Al Jurdi, Rayan K ^e,f   Forester, Brent P ^g   Kessing, Lars Vedel ^h   Beyer, John ⁱ   Manes, Facundo ^b,j,k,l   Rej, Soham ^m,n   Rosa, Adriane R ^o,p   Schouws, Sigfried N T M ^d   Tsai, Shang Ying ^q,r   Young, Robert C ^s   Shulman, Kenneth I ^m  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FAVALORO UNIVERSITY   (Argentina)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h University of Copenhagen   (Denmark)

ⁱ DUKE UNIVERSITY MEDICAL CENTER   (United States)

^j UNIVERSIDAD DIEGO PORTALES   (Chile)

^k Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^l MACQUARIE UNIVERSITY   (Australia)

^m UNIVERSITY OF TORONTO   (Canada)

ⁿ MCGILL UNIVERSITY   (Canada)

^o FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^p HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^q TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^r TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^s NEW YORK PRESBYTERIAN HOSPITAL   (United States)

more..

Author keywords

Bipolar disorder; Cognition; Elderly; Geriatric; Manic depressive disorder; Mood stabilizers

Indexed keywords

BIOLOGICAL MARKER; LITHIUM; LURASIDONE; QUETIAPINE; VALPROIC ACID; PSYCHOTROPIC AGENT;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BRAIN BIOCHEMISTRY; CEREBROVASCULAR DISEASE; CLINICAL FEATURE; COGNITION; COGNITIVE DEFECT; COMORBIDITY; CONSENSUS; DIAGNOSTIC ERROR; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HEALTH; HUMAN; MAINTENANCE THERAPY; NERVOUS SYSTEM INFLAMMATION; NEUROBIOLOGY; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OLDER AGE BIPOLAR DISORDER; ONSET AGE; OXIDATIVE STRESS; PATIENT CARE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENESCENCE; AGED; FEMALE; GERIATRIC ASSESSMENT; MALE; PATHOPHYSIOLOGY; PSYCHOLOGY;

AGE OF ONSET; AGED; BIPOLAR DISORDER; COGNITION; COMORBIDITY; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; PSYCHOTROPIC DRUGS;

EID: 84945490460     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12331     Document Type: Review

References (159)

1. World Population Ageing: 1950-2050. Available from:http://www.un.org/esa/population/publications/worldageing19502050/pdf/80chapterii.pdf [accessed April 2014].
2. Sajatovic M, Gyulai L, Calabrese JR et al. Maintenance treatment outcomes in older patients with bipolar I disorder. Am J Geriatr Psychiatry 2005; 13: 305-311.
3. Depp CA, Jeste DV. Bipolar disorder in older adults: a critical review. Bipolar Disord 2004; 6: 343-367.
4. Sajatovic M, Kessing L. Bipolar disorder in older adults: a critical review. In: Yatham LNMM ed. Bipolar Disorder - Clinical and Neurobiological Foundations. Singapore: Markono Print Media, 2010: 488-498.
5. Hirschfeld RM, Calabrese JR, Weissman MM et al. Screening for bipolar disorder in the community. J Clin Psychiatry 2003; 64: 53-59.
6. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 593-602.
7. Unutzer J, Simon G, Pabiniak C, Bond K, Katon W. The treated prevalence of bipolar disorder in a large staff-model HMO. Psychiatr Serv 1998; 49: 1072-1078.
8. Dols A, Kupka RW, van Lammeren A, Beekman AT, Sajatovic M, Stek ML. The prevalence of late-life mania: a review. Bipolar Disord 2014; 16: 113-118.
9. Depp CA, Lindamer LA, Folsom DP et al. Differences in clinical features and mental health service use in bipolar disorder across the lifespan. Am J Geriatr Psychiatry 2005; 13: 290-298.
10. Almeida OP, Fenner S. Bipolar disorder: similarities and differences between patients with illness onset before and after 65 years of age. Int Psychogeriatr 2002; 14: 311-322.
11. Prabhakar D, Balon R. Late-onset bipolar disorder: a case for careful appraisal. Psychiatry 2010; 7: 34-37.
12. Yassa R, Nair NP, Iskandar H. Late-onset bipolar disorder. Psychiatr Clin N Am 1988; 11: 117-131.
13. Vasudev A, Thomas A. 'Bipolar disorder' in the elderly: what's in a name? Maturitas 2010; 66: 231-235.
14. Azorin JM, Bellivier F, Kaladjian A et al. Characteristics and profiles of bipolar I patients according to age-at-onset: findings from an admixture analysis. J Affect Disord 2013; 150: 993-1000.
15. Leboyer M, Henry C, Paillere-Martinot ML, Bellivier F. Age at onset in bipolar affective disorders: a review. Bipolar Disord 2005; 7: 111-118.
16. Nivoli AM, Murru A, Pacchiarotti I et al. Bipolar disorder in the elderly: a cohort study comparing older and younger patients. Acta Psychiatr Scand 2014; 130: 364-373.
17. Schurhoff F, Bellivier F, Jouvent R et al. Early and late onset bipolar disorders: two different forms of manic-depressive illness? J Affect Disord 2000; 58: 215-221.
18. Cassidy F, Carroll BJ. Vascular risk factors in late onset mania. Psychol Med 2002; 32: 359-362.
19. Fujikawa T, Yamawaki S, Touhouda Y. Silent cerebral infarctions in patients with late-onset mania. Stroke 1995; 26: 946-949.
20. Hays JC, Krishnan KR, George LK, Blazer DG. Age of first onset of bipolar disorder: demographic, family history, and psychosocial correlates. Depress Anxiety 1998; 7: 76-82.
21. Bellivier F, Golmard JL, Rietschel M et al. Age at onset in bipolar I affective disorder: further evidence for three subgroups. Am J Psychiatry 2003; 160: 999-1001.
22. Oostervink F, Boomsma MM, Nolen WA, Board EA. Bipolar disorder in the elderly; different effects of age and of age of onset. J Affect Disord 2009; 116: 176-183.
23. Oostervink F, Nolen WA, Kok RM, Board EA. Two years' outcome of acute mania in bipolar disorder: different effects of age and age of onset. Int J Geriatr Psychiatry 2015; 30: 201-209.
24. Sajatovic M, Blow FC, Ignacio RV, Kales HC. New-onset bipolar disorder in later life. Am J Geriatr Psychiatry 2005; 13: 282-289.
25. Wylie ME, Mulsant BH, Pollock BG et al. Age at onset in geriatric bipolar disorder. Effects on clinical presentation and treatment outcomes in an inpatient sample. Am J Geriatr Psychiatry 1999; 7: 77-83.
26. Kessing LV. Diagnostic subtypes of bipolar disorder in older versus younger adults. Bipolar Disord 2006; 8: 56-64.
27. McGlashan TH. Adolescent versus adult onset of mania. Am J Psychiatry 1988; 145: 221-223.
28. Rosen LN, Rosenthal NE, Van Dusen PH, Dunner DL, Fieve RR. Age at onset and number of psychotic symptoms in bipolar I and schizoaffective disorder. Am J Psychiatry 1983; 140: 1523-1524.
29. Depp CA, Jin H, Mohamed S, Kaskow J, Moore DJ, Jeste DV. Bipolar disorder in middle-aged and elderly adults: is age of onset important? J Nerv Ment Dis 2004; 192: 796-799.
30. Ernst CL, Goldberg JF. Clinical features related to age at onset in bipolar disorder. J Affect Disord 2004; 82: 21-27.
31. Lish JD, Dime-Meenan S, Whybrow PC, Price RA, Hirschfeld RM. The National Depressive and Manic-depressive Association (DMDA) survey of bipolar members. J Affect Disord 1994; 31: 281-294.
32. Hirschfeld RM, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry 2003; 64: 161-174.
33. Kessing LV. Diagnostic stability in bipolar disorder in clinical practise as according to ICD-10. J Affect Disord 2005; 85: 293-299.
34. Kessing LV. Recurrence in affective disorder. II. Effect of age and gender. Br J Psychiatry 1998; 172: 29-34.
35. Kessing LV, Hansen MG, Andersen PK. Course of illness in depressive and bipolar disorders. Naturalistic study, 1994-1999. Br J Psychiatry 2004; 185: 372-377.
36. Angst J, Preisig M. Course of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985. Schweiz Arch Neurol Psychiatr 1995; 146: 5-16.
37. Kessing LV, Mortensen PB. Recovery from episodes during the course of affective disorder: a case-register study. Acta Psychiatr Scand 1999; 100: 279-287.
38. Tsai SY, Kuo CJ, Chen CC, Lee HC. Risk factors for completed suicide in bipolar disorder. J Clin Psychiatry 2002; 63: 469-476.
39. Shulman K, Tohen M, Satlin A, Mallya G, Kalunian D. Mania compared to depression in old age. Am J Psychiatry 1992; 149: 341-345.
40. Schaffer A, Isometsä ET, Tondo L et al. International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord 2015; 17: 1-16.
41. Beyer JL, Kuchibhatla M, Payne M et al. Caudate volume measurement in older adults with bipolar disorder. Int J Geriatr Psychiatry 2004; 19: 109-114.
42. Vederine FE, Wessa M, Leboyer M, Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011; 35: 1820-1826.
43. Versace A, Almeida JR, Hassel S et al. Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry 2008; 65: 1041-1052.
44. Haller S, Xekardaki A, Delaloye C et al. Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder. J Psychiatry Neurosci 2011; 36: 391-401.
45. Berk M, Kapczinski F, Andreazza AC et al. Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 2011; 35: 804-817.
46. Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry 2006; 30: 969-995.
47. Doty TJ, Payne ME, Steffens DC, Beyer JL, Krishnan KR, LaBar KS. Age-dependent reduction of amygdala volume in bipolar disorder. Psychiatry Res 2008; 163: 84-94.
48. Gildengers AG, Chung KH, Huang SH, Begley A, Aizenstein HJ, Tsai SY. Neuroprogressive effects of lifetime illness duration in older adults with bipolar disorder. Bipolar Disord 2014; 16: 617-623.
49. Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet 2000; 356: 1241-1242.
50. Hajek T, Cullis J, Novak T et al. Hippocampal volumes in bipolar disorders: opposing effects of illness burden and lithium treatment. Bipolar Disord 2012; 14: 261-270.
51. Hajek T, Kopecek M, Hoschl C, Alda M. Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis. J Psychiatry Neurosci 2012; 37: 333-343.
52. Macritchie KA, Lloyd AJ, Bastin ME et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry 2010; 196: 52-58.
53. Foland LC, Altshuler LL, Sugar CA et al. Increased volume of the amygdala and hippocampus in bipolar patients treated with lithium. NeuroReport 2008; 19: 221-224.
54. Germana C, Kempton MJ, Sarnicola A et al. The effects of lithium and anticonvulsants on brain structure in bipolar disorder. Acta Psychiatr Scand 2010; 122: 481-487.
55. Forester BP, Streeter CC, Berlow YA et al. Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am J Geriatr Psychiatry 2009; 17: 13-23.
56. Forester BP, Finn CT, Berlow YA, Wardrop M, Renshaw PF, Moore CM. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study. Bipolar Disord 2008; 10: 691-700.
57. Leboyer M, Kupfer DJ. Bipolar disorder: new perspectives in health care and prevention. J Clin Psychiatry 2010; 71: 1689-1695.
58. Leboyer M, Soreca I, Scott J et al. Can bipolar disorder be viewed as a multi-system inflammatory disease? J Affect Disord 2012; 141: 1-10.
59. Lala SV, Sajatovic M. Medical and psychiatric comorbidities among elderly individuals with bipolar disorder: a literature review. J Geriatr Psychiatry Neurol 2012; 25: 20-25.
60. Tsai SY, Kuo CJ, Chung KH, Huang YL, Lee HC, Chen CC. Cognitive dysfunction and medical morbidity in elderly outpatients with bipolar disorder. Am J Geriatr Psychiatry 2009; 17: 1004-1011.
61. Gildengers AG, Whyte EM, Drayer RA et al. Medical burden in late-life bipolar and major depressive disorders. Am J Geriatr Psychiatry 2008; 16: 194-200.
62. Westman J, Hallgren J, Wahlbeck K, Erlinge D, Alfredsson L, Osby U. Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open 2013; 3: e002373.
63. Huang SH, Chung KH, Hsu JL, Wu JY, Huang YL, Tsai SY. The risk factors for elderly patients with bipolar disorder having cerebral infarction. J Geriatr Psychiatry Neurol 2012; 25: 15-19.
64. Steffens DC, Krishnan KR. Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions. Biol Psychiatry 1998; 43: 705-712.
65. Subramaniam H, Dennis MS, Byrne EJ. The role of vascular risk factors in late onset bipolar disorder. Int J Geriatr Psychiatry 2007; 22: 733-737.
66. Tamashiro JH, Zung S, Zanetti MV et al. Increased rates of white matter hyperintensities in late-onset bipolar disorder. Bipolar Disord 2008; 10: 765-775.
67. Martino DJ, Strejilevich SA, Manes F. Neurocognitive functioning in early-onset and late-onset older patients with euthymic bipolar disorder. Int J Geriatr Psychiatry 2013; 28: 142-148.
68. Samamé C, Martino DJ, Strejilevich SA. A quantitative review of neurocognition in euthymic late-life bipolar disorder. Bipolar Disord 2013; 15: 633-644.
69. Schouws SN, Comijs HC, Stek ML et al. Cognitive impairment in early and late bipolar disorder. Am J Geriatr Psychiatry 2009; 17: 508-515.
70. Berk M, Conus P, Kapczinski F et al. From neuroprogression to neuroprotection: implications for clinical care. Med J Aust 2010; 193: S36-S40.
71. Goldstein BI, Schaffer A, Wang S, Blanco C. Excessive and premature new-onset cardiovascular disease among adults with bipolar disorder in the US NESARC cohort. J Clin Psychiatry 2015; 76: 163-169.
72. Ng F, Mammen OK, Wilting I et al. The International Society for Bipolar Disorders (ISBD) consensus guidelines for the safety monitoring of bipolar disorder treatments. Bipolar Disord 2009; 11: 559-595.
73. Ghose K. The need for a review journal of drug use and the elderly. Drugs Aging 1991; 1: 2-5.
74. Rej S, Abitbol R, Looper K, Segal M. Chronic renal failure in lithium-using geriatric patients: effects of lithium continuation versus discontinuation-a 60-month retrospective study. Int J Geriatr Psychiatry 2013; 28: 450-453.
75. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047.
76. Rej S, Herrmann N, Shulman K. The effects of lithium on renal function in older adults - a systematic review. J Geriatr Psychiatry Neurol 2012; 25: 51-61.
77. Head L, Dening T. Lithium in the over-65s: who is taking it and who is monitoring it? A survey of older adults on lithium in the Cambridge Mental Health Services catchment area. Int J Geriatr Psychiatry 1998; 13: 164-171.
78. Shulman KI, Sykora K, Gill S et al. Incidence of delirium in older adults newly prescribed lithium or valproate: a population-based cohort study. J Clin Psychiatry 2005; 66: 424-427.
79. Lipscombe LL, Levesque L, Gruneir A et al. Antipsychotic drugs and hyperglycemia in older patients with diabetes. Arch Intern Med 2009; 169: 1282-1289.
80. Setoguchi S, Wang PS, Alan Brookhart M, Canning CF, Kaci L, Schneeweiss S. Potential causes of higher mortality in elderly users of conventional and atypical antipsychotic medications. J Am Geriatr Soc 2008; 56: 1644-1650.
81. Wang PS, Schneeweiss S, Avorn J et al. Risk of death in elderly users of conventional vs. atypical antipsychotic medications. New Engl J Med 2005; 353: 2335-2341.
82. Savitz J, Drevets WC. Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide. Neurosci Biobehav Rev 2009; 33: 699-771.
83. Tsai SY, Lee HC, Chen CC, Huang YL. Cognitive impairment in later life in patients with early-onset bipolar disorder. Bipolar Disord 2007; 9: 868-875.
84. Stern Y. What is cognitive reserve? Theory and research application of the reserve concept. J Int Neuropsychol Soc 2002; 8: 448-460.
85. Cooper B, Holmes C. Previous psychiatric history as a risk factor for late-life dementia: a population-based case-control study. Age Ageing 1998; 27: 181-188.
86. da Silva J, Goncalves-Pereira M, Xavier M, Mukaetova-Ladinska EB. Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry 2013; 202: 177-186.
87. Meng X, D'Arcy C. Education and dementia in the context of the cognitive reserve hypothesis: a systematic review with meta-analyses and qualitative analyses. PLoS ONE 2012; 7: e38268.
88. Ng B, Camacho A, Lara DR, Brunstein MG, Pinto OC, Akiskal HS. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI? J Affect Disord 2008; 107: 307-315.
89. Rizzo LB, Costa LG, Mansur RB et al. The theory of bipolar disorder as an illness of accelerated aging: implications for clinical care and research. Neurosci Biobehav Rev 2014; 42: 157-169.
90. Wu KY, Chang CM, Liang HY et al. Increased risk of developing dementia in patients with bipolar disorder: a nested matched case-control study. Bipolar Disord 2013; 15: 787-794.
91. Young RC, Murphy CF, Heo M, Schulberg HC, Alexopoulos GS. Cognitive impairment in bipolar disorder in old age: literature review and findings in manic patients. J Affect Disord 2006; 92: 125-131.
92. Dhingra U, Rabins PV. Mania in the elderly: a 5-7 year follow-up. J Am Geriatr Soc 1991; 39: 581-583.
93. Delaloye C, Moy G, de Bilbao F et al. Longitudinal analysis of cognitive performances and structural brain changes in late-life bipolar disorder. Int J Geriatr Psychiatry 2011; 26: 1309-1318.
94. Depp CA, Savla GN, Moore DJ et al. Short-term course of neuropsychological abilities in middle-aged and older adults with bipolar disorder. Bipolar Disord 2008; 10: 684-690.
95. Martino DJ, Strejilevich SA, Marengo E et al. Relationship between neurocognitive functioning and episode recurrences in bipolar disorder. J Affect Disord 2013; 147: 345-351.
96. Gildengers AG, Chisholm D, Butters MA et al. Two-year course of cognitive function and instrumental activities of daily living in older adults with bipolar disorder: evidence for neuroprogression? Psychol Med 2013; 43: 801-811.
97. Schouws SN, Stek ML, Comijs HC, Dols A, Beekman AT. Cognitive decline in elderly bipolar disorder patients: a follow-up study. Bipolar Disord 2012; 14: 749-755.
98. Kessing LV, Nilsson FM. Increased risk of developing dementia in patients with major affective disorders compared to patients with other medical illnesses. J Affect Disord 2003; 73: 261-269.
99. Kessing LV, Olsen EW, Mortensen PB, Andersen PK. Dementia in affective disorder: a case-register study. Acta Psychiatr Scand 1999; 100: 176-185.
100. Kokmen E, Beard CM, Chandra V, Offord KP, Schoenberg BS, Ballard DJ. Clinical risk factors for Alzheimer's disease: a population-based case-control study. Neurology 1991; 41: 1393-1397.
101. Kessing LV, Andersen PK. Does the risk of developing dementia increase with the number of episodes in patients with depressive disorder and in patients with bipolar disorder? J Neurol Neurosurg Psychiatry 2004; 75: 1662-1666.
102. Martino DJ, Igoa A, Marengo E, Scapola M, Ais ED, Strejilevich SA. Cognitive and motor features in elderly people with bipolar disorder. J Affect Disord 2008; 105: 291-295.
103. Gigi A, Pirrotta R, Kelley-Puskas M, Lazignac C, Damsa C. [Behavior disturbances in emergency psychiatry or fronto-temporal dementia diagnosis? A challenge for psychiatrists]. Encephale 2006; 32: 775-780.
104. Goldberg JF, Chengappa KNR. Identifying and treating cognitive impairment in bipolar disorder. Bipolar Disord 2009; 11 (Suppl. 2): 123-137.
105. Torrent C, Bonnin Cdel M, Martinez-Aran A et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry 2013; 170: 852-859.
106. Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF. Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry 2011; 198: 351-356.
107. Kessing LV, Forman JL, Andersen PK. Does lithium protect against dementia? Bipolar Disord 2010; 12: 87-94.
108. Kessing LV, Sondergard L, Forman JL, Andersen PK. Lithium treatment and risk of dementia. Arch Gen Psychiatry 2008; 65: 1331-1335.
109. Young AH. More good news about the magic ion: lithium may prevent dementia. Br J Psychiatry 2011; 198: 336-337.
110. Young RC, Schulberg HC, Gildengers AG et al. Conceptual and methodological issues in designing a randomized, controlled treatment trial for geriatric bipolar disorder: GERI-BD. Bipolar Disord 2010; 12: 56-67.
111. Sajatovic M, Gildengers A, Al Jurdi RK et al. Multisite, open-label, prospective trial of lamotrigine for geriatric bipolar depression: a preliminary report. Bipolar Disord 2011; 13: 294-302.
112. Sajatovic M, Paulsson B. Quetiapine for the treatment of depressive episodes in adults aged 55 to 65 years with bipolar disorder. American Association of Geriatric Psychiatry Annual Meeting. New Orleans, LA, 2007.
113. Sajatovic M, Forester B, Tsai J et al. Efficacy and safety of lurasidone in older adults with bipolar depression: analysis of two double-blind, placebo-controlled studies. American College of Neuropsychopharmacology (ACNP) 53rd Annual Meeting. Phoenix, AZ, 2014.
114. Sajatovic M, Coconcea N, Ignacio RV et al. Aripiprazole therapy in 20 older adults with bipolar disorder: a 12-week, open-label trial. J Clin Psychiatry 2008; 69: 41-46.
115. Sajatovic M, Dines P, Fuentes-Casiano E et al. Asenapine in older adults with bipolar disorder. American Association of Geriatric Psychiatry (AAGP) Annual Meeting. Orlando, FL, 2014.
116. Abou-Saleh MT, Coppen A. Subjective side-effects of amitriptyline and lithium in affective disorders. Br J Psychiatry 1983; 142: 391-397.
117. Lepkifker E, Iancu I, Horesh N, Strous RD, Kotler M. Lithium therapy for unipolar and bipolar depression among the middle-aged and older adult patient subpopulation. Depress Anxiety 2007; 24: 571-576.
118. Yatham LN, Kennedy SH, Parikh SV et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013. Bipolar Disord 2013; 15: 1-44.
119. Sharma V, Persad E, Mazmanian D, Karunaratne K. Treatment of rapid cycling bipolar disorder with combination therapy of valproate and lithium. Can J Psychiatry Rev 1993; 38: 137-139.
120. Schaffer A, Isometsä ET, Tondo L et al. Epidemiology, neurobiology and pharmacological interventions related to suicide deaths and suicide attempts in bipolar disorder: part I of a report of the International Society for Bipolar Disorders Task Force on Suicide in Bipolar Disorder. Aust N Z J Psychaitry 2015; pii: 0004867415594427.
121. Eastham JH, Jeste DV, Young RC. Assessment and treatment of bipolar disorder in the elderly. Drugs Aging 1998; 12: 205-224.
122. Bowden CL. Lamotrigine in the treatment of bipolar disorder. Expert Opin Pharmacother 2002; 3: 1513-1519.
123. Wadzinski J, Franks R, Roane D, Bayard M. Valproate-associated hyperammonemic encephalopathy. J Am Board Fam Med 2007; 20: 499-502.
124. Shulman KI, Rochon P, Sykora K et al. Changing prescription patterns for lithium and valproic acid in old age: shifting practice without evidence. BMJ 2003; 326: 960-961.
125. Wilkins KM, Ostroff R, Tampi RR. Efficacy of electroconvulsive therapy in the treatment of nondepressed psychiatric illness in elderly patients: a review of the literature. J Geriatr Psychiatry Neurol 2008; 21: 3-11.
126. Van der Velde C. Effectiveness of lithium carbonate in the treatment of manic-depressive illness. Am J Psychiatry 1970; 127: 345-351.
127. Goldberg JF, Sacks MH, Kocsis JH. Low-dose lithium augmentation of divalproex in geriatric mania. J Clin Psychiatry 2000; 61: 304.
128. Kando JC, Tohen M, Castillo J, Zarate CA Jr. The use of valproate in an elderly population with affective symptoms. J Clin Psychiatry 1996; 57: 238-240.
129. McFarland BH, Miller MR, Straumfjord AA. Valproate use in the older manic patient. J Clin Psychiatry 1990; 51: 479-481.
130. Niedermier JA, Nasrallah HA. Clinical correlates of response to valproate in geriatric inpatients. Ann Clin Psychiatry 1998; 10: 165-168.
131. Noaghiul S, Narayan M, Nelson JC. Divalproex treatment of mania in elderly patients. Am J Geriatr Psychiatry 1998; 6: 257-262.
132. Puryear LJ, Kunik ME, Workman R Jr. Tolerability of divalproex sodium in elderly psychiatric patients with mixed diagnoses. J Geriatr Psychiatry Neurol 1995; 8: 234-237.
133. Risinger RC, Risby ED, Risch SC. Safety and efficacy of divalproex sodium in elderly bipolar patients. J Clin Psychiatry 1994; 55: 215.
134. Chen ST, Altshuler LL, Melnyk KA, Erhart SM, Miller E, Mintz J. Efficacy of lithium vs. valproate in the treatment of mania in the elderly: a retrospective study. J Clin Psychiatry 1999; 60: 181-186.
135. Young AH, McElroy SL, Bauer M et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry 2010; 71: 150-162.
136. Bayer JL, Siegal A, Kennedy JS. Olanzapine, divalproex and placebo treatment, non-head to head comparisons of older adults acute mania. 10th Congress of the International Psychogeriatric Association. Nice, France, 2001.
137. Sajatovic M. Treatment of bipolar disorder in older adults. Int J Geriatr Psychiatry 2002; 17: 865-873.
138. Baruch Y, Tadger S, Plopski I, Barak Y. Asenapine for elderly bipolar manic patients. J Affect Disord 2013; 145: 130-132.
139. Cullen M, Mitchell P, Brodaty H et al. Carbamazepine for treatment-resistant melancholia. J Clin Psychiatry 1991; 52: 472-476.
140. Sanderson DR. Use of mood stabilizers by hospitalized geriatric patients with bipolar disorder. Psychiatr Serv 1998; 49: 1145-1147.
141. Robillard M, Conn D. Gabapentin use in geriatric patients with depression and bipolar illness. Can J Psychiatry Rev 2001; 46: 764.
142. Sethi MA, Mehta R, Devanand DP. Gabapentin in geriatric mania. J Geriatr Psychiatry Neurol 2003; 16: 117-120.
143. Shulman R, Singh A, Shulman K. Treatment of elderly institutionalized bipolar patients with clozapine. Psychopharmacol Bull 1997; 33: 113-118.
144. Al Jurdi RK, Marangell LB, Petersen NJ, Martinez M, Gyulai L, Sajatovic M. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder. Am J Geriatr Psychiatry 2008; 16: 922-933.
145. Murray N, Hopwood S, Balfour DJ, Ogston S, Hewick DS. The influence of age on lithium efficacy and side-effects in out-patients. Psychol Med 1983; 13: 53-60.
146. Geddes JR, Goodwin GM, Rendell J et al. Lithium plus valproate combination therapy versus monotherapy for relapse prevention in bipolar I disorder (BALANCE): a randomised open-label trial. Lancet 2010; 375: 385-395.
147. Mueser KT, Pratt SI, Bartels SJ et al. Randomized trial of social rehabilitation and integrated health care for older people with severe mental illness. J Consult Clin Psychol 2010; 78: 561-573.
148. Bartels SJ, Pratt SI, Mueser KT et al. Long-term outcomes of a randomized trial of integrated skills training and preventive healthcare for older adults with serious mental illness. Am J Geriatr Psychiatry 2014; 22: 1251-1261.
149. Depp CA, Moore DJ, Sitzer D et al. Neurocognitive impairment in middle-aged and older adults with bipolar disorder: comparison to schizophrenia and normal comparison subjects. J Affect Disord 2007; 101: 201-209.
150. Bartels SJ, Pratt SI. Psychosocial rehabilitation and quality of life for older adults with serious mental illness: recent findings and future research directions. Curr Opin Psychiatry 2009; 22: 381-385.
151. Gildengers AG, Butters MA, Chisholm D et al. Cognition in older adults with bipolar disorder versus major depressive disorder. Bipolar Disord 2012; 14: 198-205.
152. Young RC. Evidence-based pharmacological treatment of geriatric bipolar disorder. Psychiatr Clin North Am 2005; 28: 837-869, viii.
153. Frank E, Soreca I, Swartz HA et al. The role of interpersonal and social rhythm therapy in improving occupational functioning in patients with bipolar I disorder. Am J Psychiatry 2008; 165: 1559-1565.
154. Forester BP, Zuo CS, Ravichandran C et al. Coenzyme Q10 effects on creatine kinase activity and mood in geriatric bipolar depression. J Geriatr Psychiatry Neurol 2012; 25: 43-50.
155. Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the United States. Bipolar Disord 2009; 11: 657-662.
156. Hatch J, Collinger K, Moody A, Olowoyeye O, Zhan JQ, Goldstein BI. Non-invasive vascular imaging is associated with cardiovascular risk factors among adolescents with bipolar disorder. Pediatr Cardiol 2015; 36: 158-164.
157. Berk M, Berk L, Dodd S et al. Stage managing bipolar disorder. Bipolar Disord 2014; 16: 471-477.
158. Salthouse TA. Selective review of cognitive aging. J Int Neuropsychol Soc 2010; 16: 754-760.
159. Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry 2012; 169: 790-804.